We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA approved Auvelity for the treatment of agitation in Alzheimer's disease. First non-antipsychotic agent without mortality risk. Learn about the new standard of therapy.
